209 related articles for article (PubMed ID: 34601110)
1. How to taper glucocorticoids in inflammatory rheumatic diseases? A narrative review of novel evidence in rheumatoid arthritis, systemic lupus erythematosus, and giant cell arteritis.
Buttgereit F; Palmowski A
Joint Bone Spine; 2022 Jan; 89(1):105285. PubMed ID: 34601110
[TBL] [Abstract][Full Text] [Related]
2. Continuing versus tapering low-dose glucocorticoids in patients with rheumatoid arthritis and systemic lupus erythematosus in states of low disease activity or remission: A systematic review and meta-analysis of randomised trials.
Palmowski A; Pankow A; Terziyska K; Nielsen SM; Christensen R; Bliddal H; Boyadzhieva Z; Buttgereit F
Semin Arthritis Rheum; 2024 Feb; 64():152349. PubMed ID: 38100900
[TBL] [Abstract][Full Text] [Related]
3. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.
Burmester GR; Buttgereit F; Bernasconi C; Álvaro-Gracia JM; Castro N; Dougados M; Gabay C; van Laar JM; Nebesky JM; Pethoe-Schramm A; Salvarani C; Donath MY; John MR;
Lancet; 2020 Jul; 396(10246):267-276. PubMed ID: 32711802
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System.
Strehl C; Ehlers L; Gaber T; Buttgereit F
Front Immunol; 2019; 10():1744. PubMed ID: 31396235
[TBL] [Abstract][Full Text] [Related]
5. Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering.
Venerito V; Emmi G; Cantarini L; Leccese P; Fornaro M; Fabiani C; Lascaro N; Coladonato L; Mattioli I; Righetti G; Malandrino D; Tangaro S; Palermo A; Urban ML; Conticini E; Frediani B; Iannone F; Lopalco G
Front Immunol; 2022; 13():860877. PubMed ID: 35450069
[TBL] [Abstract][Full Text] [Related]
6. Tocilizumab: a novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases.
Alten R; Maleitzke T
Ann Med; 2013 Jun; 45(4):357-63. PubMed ID: 23650978
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study.
Floris A; Chessa E; Sebastiani GD; Prevete I; Iannone F; Coladonato L; Govoni M; Bortoluzzi A; Mosca M; Tani C; Doria A; Iaccarino L; Franceschini F; Fredi M; Conti F; Spinelli FR; Bellisai F; D'Alessandro R; Zanetti A; Carrara G; Scirè CA; Cauli A; Piga M;
RMD Open; 2022 Dec; 8(2):. PubMed ID: 36581383
[TBL] [Abstract][Full Text] [Related]
8. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
[TBL] [Abstract][Full Text] [Related]
9. Predictors of corticosteroid tapering in SLE patients: the Hopkins Lupus Cohort.
Zahr ZA; Fang H; Magder LS; Petri M
Lupus; 2013 Jun; 22(7):697-701. PubMed ID: 23708944
[TBL] [Abstract][Full Text] [Related]
10. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.
Zink A; Fischer-Betz R; Thiele K; Listing J; Huscher D; Gromnica-Ihle E; Specker C; Schneider M;
Lupus; 2004; 13(7):529-36. PubMed ID: 15352425
[TBL] [Abstract][Full Text] [Related]
11. Conventional versus Rapid Glucocorticoid Tapering in Severe Systemic Lupus Erythematosus Patients: A Non-Blind, Randomized Controlled Trial.
Abe Y; Fujibayashi K; Nishizaki Y; Yanagisawa N; Nojiri S; Kon T; Tada K; Yamaji K; Tamura N
Acta Med Okayama; 2020 Apr; 74(2):179-183. PubMed ID: 32341595
[TBL] [Abstract][Full Text] [Related]
12. [From pathogenesis of giant cell arteritis to new therapeutic targets].
Samson M; Bonnotte B
Rev Med Interne; 2017 Oct; 38(10):670-678. PubMed ID: 28800947
[TBL] [Abstract][Full Text] [Related]
13. PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
Ramirez GA; Rovere-Querini P; Blasi M; Sartorelli S; Di Chio MC; Baldini M; De Lorenzo R; Bozzolo EP; Leone R; Mantovani A; Manfredi AA; Tombetti E
Front Immunol; 2019; 10():1135. PubMed ID: 31191526
[TBL] [Abstract][Full Text] [Related]
14. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ
Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646
[TBL] [Abstract][Full Text] [Related]
15. Low-dose glucocorticoids withdrawn in systemic lupus erythematosus: a desirable and attainable goal.
Ji L; Gao D; Hao Y; Huang H; Wang Y; Deng X; Geng Y; Zhang Z
Rheumatology (Oxford); 2022 Dec; 62(1):181-189. PubMed ID: 35412598
[TBL] [Abstract][Full Text] [Related]
16. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus.
Cohen S; Clowse M; Pardo P; Bhattacharya I; Menon S; Gourley I; Diehl A
Clin Ther; 2016 Jun; 38(6):1417-1434.e2. PubMed ID: 27112532
[TBL] [Abstract][Full Text] [Related]
17. A comparison of rheumatoid arthritis and systemic lupus erythematosus trial design: a commentary on ways to improve the number of positive trials in SLE.
Miles A; Pope JE
Clin Exp Rheumatol; 2015; 33(5):671-80. PubMed ID: 26315693
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
Hellmich B; Águeda AF; Monti S; Luqmani R
Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642
[TBL] [Abstract][Full Text] [Related]
19. Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date.
Lazzerini PE; Capecchi PL; Guidelli GM; Selvi E; Acampa M; Laghi-Pasini F
Drug Des Devel Ther; 2016; 10():3083-3098. PubMed ID: 27713619
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A
Patel NJ; Tozzo V; Higgins JM; Stone JH
Arthritis Rheumatol; 2023 Apr; 75(4):586-594. PubMed ID: 36383175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
